
Pet healthcare is witnessing a surge in demand as more households prioritize their pets’ well-being, driving companies in this sector to outperform expectations. This trend is reflected in IDEXX Laboratories Inc.‘s (NASDAQ:IDXX) recent financial results, showcasing significant growth and revised earnings guidance.
IDEXX Laboratories on Monday reported second-quarter 2025 adjusted earnings of $3.50, up 17% year over year, beating the consensus of $3.28.